Parkinson Disease study: Red Light
Official title Light Therapy Intervention in Individuals With Parkinson's Disease
ClinicalTrials.gov ID: NCT06916260
What this study is testing
- What it's testing
- The study aims to see if low‑level light to the frontal cortex can change Parkinson’s motor and thinking problems.
- Who it's for
- People with Parkinson’s disease who can attend regular visits.
- What's involved
- Participants receive 12‑minute light sessions three times a week for six weeks, and take cognitive and motor tests before and after the program.
- Time commitment
- The program lasts six weeks, with three light‑therapy sessions each week and pre‑ and post‑testing visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Diagnosis of Parkinson disease
You likely can't join if
- Participants who are unable to comply with study visit/testing requirements (e.g.
- Participants who are unable to provide consent.
- Participants with a Deep Brain Stimulation (DBS) device.
- Participants who have a history of a psychiatric disorder
- Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
- Participants with a clinical diagnosis of PD that is not considered primary (e.g.
See the full eligibility criteria
- Diagnosis of Parkinson disease
- Participants who are unable to comply with study visit/testing requirements (e.g. participants who cannot go off PD medication for the pre-, post-, and 3-month assessments).
- Participants who are unable to provide consent.
- Participants with a Deep Brain Stimulation (DBS) device.
- Participants who have a history of a psychiatric disorder
- Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
- Participants with a clinical diagnosis of PD that is not considered primary (e.g. vascular parkinsonism) or participants where an atypical form of parkinsonism is suspected (e.g., progressive supranuclear palsy...
- Participants with a history of cancer (whether treated with chemotherapy and/or radiotherapy or not).
- Participants with a history of a recent concussion or any facial, neck, or head injury within the last 6 months. UD IRB Approved: 03/12/2025 IRBNet ID#: 2277769-2 I/C from Rev.
- Known injury or disease that might interfere with motor function in the proposed experiments (e.g., stroke, traumatic brain injury, extrapyramidal dysfunction, neuromuscular disease, orthopedic problems that impair...
- Participants with a history of photosensitivity.
- Participants who are not able to walk unassisted for 2 minutes
The study team makes the final eligibility decision.
Where it is enrolling
- Newark, Delaware, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Newark, Delaware, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.